PharmaPoint Latest News

A major paradigm shift in late and mid-stage product development from anti-resorptive therapies to anabolic drugs will prove the key driver in the global osteoporosis market, states research and consulting firm GlobalData.

Established players are investing heavily to maintain their presence in the increasingly competitive Multiple Sclerosis (MS) therapy market, states a new report by GlobalData.

This report provides an overrview of epilepsy, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines

This report provides comprehensive information on prostate cancer therapeutics, highlighting the treatment guidelines and identifying and analyzing key trends shaping the market

This report provides detailed information on the global seasonal influenza market.